- Home
- UONEK vs ACHL Comparison
UONEK vs ACHL Comparison
Compare UONEK & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- ACHL
- Stock Information
- Founded
- UONEK 1980
- ACHL 2016
- Country
- UONEK United States
- ACHL United Kingdom
- Employees
- UONEK N/A
- ACHL N/A
- Industry
- UONEK Broadcasting
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UONEK Consumer Discretionary
- ACHL Health Care
- Exchange
- UONEK Nasdaq
- ACHL Nasdaq
- Market Cap
- UONEK 46.9M
- ACHL 46.8M
- IPO Year
- UONEK N/A
- ACHL 2021
- Fundamental
- Price
- UONEK $0.93
- ACHL $1.14
- Analyst Decision
- UONEK
- ACHL Buy
- Analyst Count
- UONEK 0
- ACHL 2
- Target Price
- UONEK N/A
- ACHL $4.00
- AVG Volume (30 Days)
- UONEK 29.3K
- ACHL 266.7K
- Earning Date
- UONEK 11-12-2024
- ACHL 11-14-2024
- Dividend Yield
- UONEK N/A
- ACHL N/A
- EPS Growth
- UONEK N/A
- ACHL N/A
- EPS
- UONEK N/A
- ACHL N/A
- Revenue
- UONEK $452,891,000.00
- ACHL N/A
- Revenue This Year
- UONEK N/A
- ACHL N/A
- Revenue Next Year
- UONEK N/A
- ACHL N/A
- P/E Ratio
- UONEK N/A
- ACHL N/A
- Revenue Growth
- UONEK N/A
- ACHL N/A
- 52 Week Low
- UONEK $0.81
- ACHL $0.63
- 52 Week High
- UONEK $3.96
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- UONEK 43.77
- ACHL 55.79
- Support Level
- UONEK $0.94
- ACHL $1.12
- Resistance Level
- UONEK $1.03
- ACHL $1.18
- Average True Range (ATR)
- UONEK 0.06
- ACHL 0.05
- MACD
- UONEK -0.01
- ACHL -0.00
- Stochastic Oscillator
- UONEK 52.27
- ACHL 33.33
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.